monkeypox virus

GPTKB entity

Statements (57)
Predicate Object
gptkbp:instance_of gptkb:virus
gptkbp:animal_hosts monkeys
prairie dogs
squirrels
gptkbp:cause monkeypox disease
gptkbp:community_health community education
contact tracing
surveillance measures
global health concern
potential for outbreaks
gptkbp:death 1% to 10%
gptkbp:diagnosis serological testing
PCR testing
similarity to chickenpox
similarity to other poxviruses
gptkbp:endemic_to gptkb:Nigeria
gptkb:Democratic_Republic_of_the_Congo
gptkbp:epidemiology case tracking important
underreported cases possible
gptkbp:geographic_distribution Central Africa
West Africa
https://www.w3.org/2000/01/rdf-schema#label monkeypox virus
gptkbp:human_cases reported globally
increased incidence in 2022
gptkbp:incubation_period 7 to 14 days
up to 21 days
gptkbp:is_recognized_as gptkb:1970
gptkbp:is_similar_to variola virus
cowpox virus
gptkbp:is_vulnerable_to smallpox vaccine
gptkbp:prevention isolation of infected individuals
avoid contact with infected animals
gptkbp:provides_guidance_on CDC recommendations
WHO guidelines
gptkbp:public_awareness health campaigns
increased media coverage
gptkbp:research vaccine efficacy studies
ongoing studies on transmission
gptkbp:reservoir rodents
gptkbp:risk_factor travel to endemic areas
contact with infected animals
close contact with infected individuals
gptkbp:scientific_classification notifiable disease
gptkbp:symptoms fever
rash
swollen lymph nodes
skin lesions
2 to 4 weeks
flu-like symptoms
gptkbp:transmission zoonotic transmission
gptkbp:treatment supportive care
antiviral medications
investigational therapies
clinical trials ongoing
vaccination post-exposure
gptkbp:variant Clade I
Clade II